Topal, A. and Başak, M. 2025. Evaluating the role of HER2-low versus HER2-0 status in predicting response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer. The European Research Journal. 11, 5 (Sep. 2025), 858–867. DOI:https://doi.org/10.18621/eurj.1704067.